Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles

International Journal of Cancer

Volumn 137, Issue 7, 2015, Pages 1539-1548

  Marien, Eyra ^a   Meister, Michael ^b,c   Muley, Thomas ^b,c   Fieuws, Steffen ^d   Bordel, Sergio ^e   Derua, Rita ^f   Spraggins, Jeffrey ^g   Van De Plas, Raf ^g,h   Dehairs, Jonas ^a   Wouters, Jens ^a   Bagadi, Muralidhararao ^a   Dienemann, Hendrik ^b,c   Thomas, Michael ^b,c   Schnabel, Philipp A ^c,i   Caprioli, Richard M ^g   Waelkens, Etienne ^f   Swinnen, Johannes V ^a  

^a KU Leuven and University Hospitals Leuven and Leuven Cancer Institute   (Belgium)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Member of the German Center for Lung Research   (Germany)

^d KU LEUVEN   (Belgium)

^e CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^f LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

^g VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

ⁱ UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

2D imaging MS; lipidomics; mass spectrometry; non small cell lung cancer; phospholipids

Indexed keywords

PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; SPHINGOMYELIN;

AREA UNDER THE CURVE; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL FUNCTION; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID METABOLISM; LIPIDOMICS; LUNG CANCER CELL LINE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METASTASIS POTENTIAL; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL LUNG CARCINOMA; CHEMISTRY; LUNG TUMOR; METABOLISM; PROCEDURES; TANDEM MASS SPECTROMETRY;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; PHOSPHATIDYLINOSITOLS; PHOSPHOLIPIDS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPHINGOMYELINS; TANDEM MASS SPECTROMETRY;

EID: 84964695291     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29517     Document Type: Article

References (34)

1. Globocan. In: Cancer IAfRo, ed., 2012. Available at: http://globocan.iarc.fr/. (Accessed on: Sept 30, 2014).
2. Zhang Q, Li H, Jin H, et al., The global landscape of intron retentions in lung adenocarcinoma. BMC Med Genomics 2014; 7: 15
3. Tan DS, Camilleri-Broet S, Tan EH, et al., Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics. Int J Cancer 2014; 135: 1092-100.
4. Lazar V, Suo C, Orear C, et al., Integrated molecular portrait of non-small cell lung cancers. BMC Med Genomics 2013; 6: 53
5. Zhang L, Zhang W, Chen K,. Search for cancer risk factors with microarray-based genome-wide association studies. Technol Cancer Res Treat 2010; 9: 107-21.
6. Lane AN, Fan TW, Bousamra M, II, et al., Stable isotope-resolved metabolomics (SIRM) in cancer research with clinical application to nonsmall cell lung cancer. Omics 2011; 15: 173-82. [PMC][10.1089/omi.2010.0088] [21329461]
7. Kisluk J, Ciborowski M, Niemira M, et al., Proteomics biomarkers for non-small cell lung cancer. J Pharm Biomed Anal 2014; 101: 40-9.
8. Laganowsky A, Reading E, Allison TM, et al., Membrane proteins bind lipids selectively to modulate their structure and function. Nature 2014; 510: 172-5.
9. Rysman E, Brusselmans K, Scheys K, et al., De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. Cancer Res 2010; 70: 8117-26.
10. Swinnen JV, Van Veldhoven PP, Timmermans L, et al., Fatty acid synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains. Biochem Biophys Res Commun 2003; 302: 898-903.
11. Menendez JA, Lupu R,. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007; 7: 763-77.
12. Scott KF, Sajinovic M, Hein J, et al., Emerging roles for phospholipase a2 enzymes in cancer. Biochimie 2010; 92: 601-10.
13. Igal RA,. Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer. Carcinogenesis 2010; 31: 1509-15.
14. Visca P, Sebastiani V, Botti C, et al., Fatty acid synthase (FAS) is a marker of increased risk of recurrence in lung carcinoma. Anticancer Res 2004; 24: 4169-73.
15. Noto A, Raffa S, De Vitis C, et al., Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells. Cell Death Dis 2013; 4: e947
16. Caprioli RM, Farmer TB, Gile J,. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem 1997; 69: 4751-60.
17. Hankin JA, Barkley RM, Murphy RC,. Sublimation as a method of matrix application for mass spectrometric imaging. J Am Soc Mass Spectrom 2007; 18: 1646-52.
18. Benjamini Y, Hochberg Y,. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodological) 1995; 57: 289-300.
19. Gonen M, Heller G,. Lehmann family of ROC curves. Med Decis Making 2010; 30: 509-17.
20. Arafah K, Longuespee R, Desmons A, et al., Lipidomics for clinical diagnosis: Dye-assisted laser desorption/ionization (DALDI) method for lipids detection in MALDI mass spectrometry imaging. Omics 2014; 18: 487-98.
21. Zhou X, Mao J, Ai J, et al., Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformatics. PLoS One 2012; 7: e48889
22. Hilvo M, Denkert C, Lehtinen L, et al., Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. Cancer Res 2011; 71: 3236-45.
23. Fumarola C, Bonelli MA, Petronini PG, et al., Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer. Biochem Pharmacol 2014; 90: 197-207.
24. Eberlin LS, Gabay M, Fan AC, et al., Alteration of the lipid profile in lymphomas induced by MYC overexpression. Proc Natl Acad Sci USA 2014; 111: 10450-55.
25. Mitani S, Kamata H, Fujiwara M, et al., Analysis of c-myc DNA amplification in non-small cell lung carcinoma in comparison with small cell lung carcinoma using polymerase chain reaction. Clin Exp Med 2001; 1: 105-11.
26. Hammerman PS, Lawrence MS, Voet D, et al., Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012; 489: 519-25.
27. Medina MA, Marquez J, Nunez de Castro I,. Interchange of amino acids between tumor and host. Biochem Med Metab Biol 1992; 48: 1-7.
28. Barcelo-Coblijn G, Martin ML, de Almeida RF, et al., Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy. Proc Natl Acad Sci USA 2011; 108: 19569-74.
29. Dillehay DL, Webb SK, Schmelz EM, et al., Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in cf1 mice. J Nutr 1994; 124: 615-20.
30. Lemonnier LA, Dillehay DL, Vespremi MJ, et al., Sphingomyelin in the suppression of colon tumors: prevention versus intervention. Arch Biochem Biophys 2003; 419: 129-38.
31. Modrak DE, Lew W, Goldenberg DM, et al., Sphingomyelin potentiates chemotherapy of human cancer xenografts. Biochem Biophys Res Commun 2000; 268: 603-6.
32. Doria ML, Ribeiro AS, Wang J, et al., Fatty acid and phospholipid biosynthetic pathways are regulated throughout mammary epithelial cell differentiation and correlate to breast cancer survival. Faseb J 2014; 28: 4247-64.
33. Lee GK, Lee HS, Park YS, et al., Lipid MALDI profile classifies non-small cell lung cancers according to the histologic type. Lung Cancer 2012; 76: 197-203.
34. Balog J, Sasi-Szabo L, Kinross J, et al., Intraoperative tissue identification using rapid evaporative ionization mass spectrometry. Sci Transl Med 2013; 5: 194ra9.